37th AGM notice and Annual Report for FY2025-26 filed

Revenue Growth 20pctPat NegativeExceptional ItemRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹33.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+0.6% vs market

Pharmaceuticals peers, median of 175sector-0.6%+0.6% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-0.6+0.6-0.6+0.6

Next day

-2.8-0.1-2.7-0.1-2.7

-1.3+0.2-1.5-0.1-1.2

-6.7+0.4-7.1-0.3-6.4

-4.7+0.0-4.7-0.7-4.0

-3.0+0.6-3.6+0.0-3.1

-3.2+0.7-3.8+0.5-3.7

15d

-8.5+1.5-9.9+1.1-9.6

-8.6+0.2-8.8+1.9-10.6

-9.1-3.7-5.4-4.4-4.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pharmaids filed its 37th AGM notice and Annual Report for FY2025-26. Standalone revenue surged from Rs 335.98 Lakhs to Rs 1,126.29 Lakhs (around 235 percent growth). However, net loss widened from Rs 727.92 Lakhs to Rs 1,043.72 Lakhs, with EPS at minus Rs 2.95. New promoters joined in September 2025. Company sold land to a promoter for Rs 19.35 crores (related party deal) and exited Anugraha Chemicals for Rs 1,023.65 Lakhs. No dividend declared.

Likely market impact

Revenue growth is strong but losses are deepening year on year. Related party land sale to new promoter may raise governance concerns.